Secondary prevention following myocardial infarct. Which drug treatment is safe today?
Bungeroth, K.A.
Fortschritte der Medizin 105(31): 607-611
1987
ISSN/ISBN: 0015-8178 PMID: 2891595 Document Number: 304487
Document emailed within 1 workday
Related Documents
Paragh, G.; Balogh, Z.; Boda, J.; Mohácsi, A.; Kovács, P.; Polgár, P.; Wórum, F.; Kakuk, G. 1997: Lipid lowering treatment in secondary prevention following myocardial infarct Orvosi Hetilap 138(29): 1849-1853Follath, F. 1986: Secondary prevention following myocardial infarct Schweizerische Rundschau für Medizin Praxis 75(40): 1177-1180
Bocková, E.; Polácková, J. 1985: Behavior pattern in the secondary prevention of myocardial infarct Ceskoslovenska Psychiatrie 81(2): 96-99
Einecke, D. 2011: Secondary prevention. Pills without co-pay reduce complications after myocardial infarct MMW Fortschritte der Medizin 153(48): 15
Di Pasquale, G.; Ottani, F.; Ceré, E.; Biancoli, S.; Sassone, B.; Lombardi, A. 1998: Platelet antiaggregants or anticoagulants in the secondary prevention after myocardial infarct Recenti Progressi in Medicina 89(10): 514-519
Schilling, J.; Schwendinger, M.; Vranjes, N.; Gutzwiller, F. 1996: Thrombolysis following myocardial infarct. European Secondary Prevention Study Praxis 85(42): 1311-1315
de Jonge, F.A.; Jonker, J.J. 1983: New study on the secondary prevention of myocardial infarct using oral anticoagulants Nederlands Tijdschrift Voor Geneeskunde 127(31): 1391-1394
Nightingale, A.; Marshall, A. 1998: Secondary prevention in acute myocardial infarction. Long term insulin treatment is important in secondary prevention in diabetic patients Bmj 317(7166): 1153
2003: Aggressive and early combined drug therapy. Antidiabetics for prevention of myocardial infarct MMW Fortschritte der Medizin 145(25): 52
Yamamoto, Y. 1986: Prevention and treatment of cardiogenic shock associated with acute myocardial infarct Nursing Technique 32(7): 828-832
Sarasin, C.; Pfisterer, M.; Weiss, P. 1992: Is it justifiable today to perform thrombolysis in only one fifth of the patients with myocardial infarct? Schweizerische Medizinische Wochenschrift 122(11): 369-374
Kleber, F.X.; Baumann, G. 1993: Significance of treatment of early forms and prevention of heart failure. Value of ACE inhibitors in therapy after myocardial infarct Acta Medica Austriaca 20(4): 95-99
Yoshida, S.; Miura, T.; Matsuki, T.; Iimura, K. 1985: Recent trends in the management of myocardial infarct--drug therapy of acute myocardial infarction Hokkaido Journal of Medical Science 60(6): 801-805
Stoupel, E. 1982: Stress, causative factor of or secondary reaction to myocardial infarct Revue Medicale de Liege 37(Suppl 1): 25-28
Bazzocchi, R.; Descovich, P.; Descovich, G.C. 1970: Excision of the infarct in surgical treatment of experimental myocardial infarct Acta Chirurgia Italiana 26(4): 289-334
Diener, H.C.; Weiller, C. 1993: Ticlopidine. Secondary prevention of ischemic cerebral infarct Der Internist 34(12): 1150-1155
Schauer, J.; Harksel, B.; Harksel, K. 1987: Effect of secondary bronchopulmonary diseases on the performance and course of rehabilitation of patients with myocardial infarct Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 42(7): 182-187
Burkart, F. 1985: Prevention of myocardial infarct and of reinfarction Therapeutische Umschau. Revue Therapeutique 42(8): 511-520
Santoro, G.M.; Sciagrà, R.; Bisi, G.; Leoncini, M.; Meldolesi, U.; Fazzini, P.F. 1990: Ealuation of thrombolytic treatment of acute myocardial infarct using myocardial scintigraphy with Tc-99-MIBI. Immediate results and follow-up after one year Giornale Italiano di Cardiologia 20(11): 987-996
Haass, A. 1989: Drug prevention of ischemic cerebral infarct Verhandlungen der Deutschen Gesellschaft für Innere Medizin 95: 297-304